简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

艾弗雷什公司和奥多纳特治疗公司的证券在纳斯达克市场退市

2022-01-25 05:16

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of iFresh Inc. iFresh Inc.'s common stock was suspended on November 23, 2021 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.'s common stock was suspended on January 18, 2022 and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

NDAQO


风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。